Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristyn Galbraith

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Neuro-Oncology|April 28, 2025
DNA methylation profiling of pituitary neuroendocrine tumors identifies distinct clinical and pathological subtypes based on epigenetic differentiationSarra Belakhoua, Varshini Vasudevaraja, Chanel Schroff, et al.
Nature Nanotechnology|December 24, 2025
Machine perception liquid biopsy identifies brain tumours via systemic immune and tumour microenvironment signatureDana Goerzen, Mijin Kim, Chanel Schroff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2024
T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B Status in IDH-Mutant AstrocytomasMatthew D Lee, Rajan Jain, Kristyn Galbraith, et al.
Journal of Neuropathology and Experimental Neurology|August 4, 2020
Anaplastic Transformation in Myxopapillary Ependymoma: A Report of 2 Cases and Review of the LiteratureLorenzo Gitto, Serenella Serinelli, Kristyn Galbraith, et al.
Journal of Neuropathology and Experimental Neurology|August 23, 2022
Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord GliomasMekka R Garcia, Yang Feng, Varshini Vasudevaraja, et al.
Journal of Neuropathology and Experimental Neurology|November 28, 2024
Deep learning-based classifier for carcinoma of unknown primary using methylation quantitative trait lociAdam Walker, Camila S Fang, Chanel Schroff, et al.
Pigment Cell & Melanoma Research|September 10, 2024
MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical ModelsAlcida Karz, Nicolas Coudray, Erol Bayraktar, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
A developmentally regulated long-range enhancer-promoter contact mediates human neural developmentDevin Bready, Shuai Wang, Niklas Ravn-Boess, et al.
Acta Neuropathologica Communications|November 3, 2023
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation resultsMatthew McCord, Pouya Jamshidi, Vineeth Thirunavu, et al.
The Journal of Molecular Diagnostics : JMD|March 1, 2025
Detection of Gene Fusions and Rearrangements in Formalin-Fixed, Paraffin-Embedded Solid Tumor Specimens Using High-Throughput Chromosome Conformation CaptureKristyn Galbraith, Jamin Wu, Kristin Sikkink, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Neuro-Oncology|April 28, 2025
DNA methylation profiling of pituitary neuroendocrine tumors identifies distinct clinical and pathological subtypes based on epigenetic differentiationSarra Belakhoua, Varshini Vasudevaraja, Chanel Schroff, et al.
Nature Nanotechnology|December 24, 2025
Machine perception liquid biopsy identifies brain tumours via systemic immune and tumour microenvironment signatureDana Goerzen, Mijin Kim, Chanel Schroff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2024
T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B Status in IDH-Mutant AstrocytomasMatthew D Lee, Rajan Jain, Kristyn Galbraith, et al.
Journal of Neuropathology and Experimental Neurology|August 4, 2020
Anaplastic Transformation in Myxopapillary Ependymoma: A Report of 2 Cases and Review of the LiteratureLorenzo Gitto, Serenella Serinelli, Kristyn Galbraith, et al.
Journal of Neuropathology and Experimental Neurology|August 23, 2022
Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord GliomasMekka R Garcia, Yang Feng, Varshini Vasudevaraja, et al.
Journal of Neuropathology and Experimental Neurology|November 28, 2024
Deep learning-based classifier for carcinoma of unknown primary using methylation quantitative trait lociAdam Walker, Camila S Fang, Chanel Schroff, et al.
Pigment Cell & Melanoma Research|September 10, 2024
MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical ModelsAlcida Karz, Nicolas Coudray, Erol Bayraktar, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
A developmentally regulated long-range enhancer-promoter contact mediates human neural developmentDevin Bready, Shuai Wang, Niklas Ravn-Boess, et al.
Acta Neuropathologica Communications|November 3, 2023
Variant allelic frequencies of driver mutations can identify gliomas with potentially false-negative MGMT promoter methylation resultsMatthew McCord, Pouya Jamshidi, Vineeth Thirunavu, et al.
The Journal of Molecular Diagnostics : JMD|March 1, 2025
Detection of Gene Fusions and Rearrangements in Formalin-Fixed, Paraffin-Embedded Solid Tumor Specimens Using High-Throughput Chromosome Conformation CaptureKristyn Galbraith, Jamin Wu, Kristin Sikkink, et al.
Pageof 3